Insider Transactions in Q4 2022 at 1 Life Healthcare Inc (ONEM)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,116
-30.84%
|
$97,856
$16.72 P/Share
|
|
Dec 01
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-1.0%
|
$3,400
$17.0 P/Share
|
|
Nov 21
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,102
-4.44%
|
$65,632
$16.58 P/Share
|
|
Nov 21
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+2.19%
|
$45,122
$11.52 P/Share
|
|
Nov 17
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,312
-4.65%
|
$68,992
$16.71 P/Share
|
|
Nov 17
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
761
-3.66%
|
$12,176
$16.7 P/Share
|
|
Nov 16
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,230
-4.36%
|
$67,680
$16.82 P/Share
|
|
Nov 16
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,935
-15.91%
|
$62,960
$16.81 P/Share
|
|
Nov 15
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
11,014
+5.37%
|
$132,168
$12.16 P/Share
|
|
Nov 15
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,472
-2.72%
|
$39,552
$16.84 P/Share
|
|
Nov 15
2022
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,542
+45.29%
|
-
|
|
Nov 15
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,251
+29.3%
|
-
|
|
Nov 01
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,417
-41.84%
|
$177,089
$17.1 P/Share
|
|
Nov 01
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,417
+29.5%
|
$72,919
$7.93 P/Share
|
|
Oct 24
2022
|
Andrew S Diamond Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
293,185
-99.4%
|
$4,984,145
$17.08 P/Share
|
|
Oct 24
2022
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
184,211
+17.74%
|
$1,473,688
$8.66 P/Share
|
|
Oct 21
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,602
-1.78%
|
$27,234
$17.08 P/Share
|
|
Oct 21
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,602
+1.75%
|
$17,622
$11.56 P/Share
|
|
Oct 19
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,500
-2.75%
|
$42,500
$17.06 P/Share
|
|
Oct 19
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.68%
|
$27,500
$11.47 P/Share
|
|
Oct 17
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,472
-2.72%
|
$42,024
$17.06 P/Share
|
|
Oct 17
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,472
+2.65%
|
$29,664
$12.16 P/Share
|
|
Oct 15
2022
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
730
+1.54%
|
-
|
|
Oct 15
2022
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
730
+9.44%
|
-
|
|
Oct 15
2022
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
730
+7.11%
|
-
|
|
Oct 15
2022
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,023
+8.15%
|
-
|
|
Oct 15
2022
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,023
+8.15%
|
-
|
|
Oct 12
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,610
+46.55%
|
$88,270
$7.93 P/Share
|
|
Oct 07
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
1,371,117
-93.22%
|
$23,308,989
$17.03 P/Share
|
|
Oct 07
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,371,117
+31.01%
|
$9,597,819
$7.79 P/Share
|
|
Oct 06
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
1,825,289
-94.82%
|
$31,029,913
$17.08 P/Share
|
|
Oct 06
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,825,289
+48.67%
|
$7,301,156
$4.01 P/Share
|
|
Oct 05
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
2,123,402
-95.51%
|
$36,097,834
$17.09 P/Share
|
|
Oct 05
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,123,402
+48.85%
|
$8,493,608
$4.01 P/Share
|
|
Oct 04
2022
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
133,838
-60.23%
|
$2,275,246
$17.18 P/Share
|
|
Oct 04
2022
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
133,838
+17.03%
|
$1,338,380
$10.74 P/Share
|
|
Oct 04
2022
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
325,575
-99.43%
|
$5,534,775
$17.18 P/Share
|
|
Oct 04
2022
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
298,570
+47.69%
|
$2,089,990
$7.93 P/Share
|
|
Oct 04
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Indirect |
249,377
-75.0%
|
$4,239,409
$17.18 P/Share
|
|
Oct 04
2022
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
1,613,937
-94.18%
|
$27,436,929
$17.17 P/Share
|
|
Oct 04
2022
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,613,937
+24.93%
|
$6,455,748
$4.01 P/Share
|